Login
$IQV
$264.73 +$0.00 (0.0%) After hours

$IQV 8-K SEC Filings

Filed On Filing
27 Oct 2026 8-K: Results of Operations and Financial Condition

RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – October 27, 2026 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences a...

23 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

Form of Supplemental Indenture to Be Delivered by Subsequent Guarantors

09 Sep 2026 8-K: Other Events

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2...

28 Jul 2026 8-K: Results of Operations and Financial Condition

RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – July 28, 2026 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and ...

11 Jun 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

Form of Supplemental Indenture to Be Delivered by Subsequent Guarantors

04 Jun 2026 8-K: Other Events

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €950,000,000 in aggregate principal amount of senior notes due 203...

03 Jun 2026 8-K: Other Events

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €950,000,000 through an offering of senior notes due 2033 (the “Notes”).

07 May 2026 8-K: Other Events

Kerri Joseph, IQVIA Investor Relations ([email protected])

05 May 2026 8-K: Results of Operations and Financial Condition

RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – May 5, 2026 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and he...

23 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

1. Purpose. The purpose of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan is to further align the interests of eligible participants with those of the Company’s stockholders by providing incentive compensation opportunities ...

05 Feb 2026 8-K: Results of Operations and Financial Condition

RESEARCH TRIANGLE PARK, N.C. – February 5, 2026 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare indu...

09 Dec 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

AMENDMENT NO. 5, dated as of December 9, 2025 (this “Amendment”), among IQVIA Inc., a Delaware corporation (the “Parent Borrower”), IQVIA RDS Inc., a North Carolina corporation and a subsidiary of the Parent Borrower (the “U.S. Borrower”...

05 Nov 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Kerri Joseph, IQVIA Investor Relations ([email protected])

28 Oct 2025 8-K: Results of Operations and Financial Condition

RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – October 28, 2025 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences a...

02 Sep 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Kerri Joseph, IQVIA Investor Relations ([email protected])

22 Jul 2025 8-K: Results of Operations and Financial Condition

RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – July 22, 2025 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and ...

04 Jun 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

Form of Supplemental Indenture to Be Delivered by Subsequent Guarantors

02 Jun 2025 8-K: Other Events

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2...

06 May 2025 8-K: Results of Operations and Financial Condition

RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – May 6, 2025 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and he...

24 Apr 2025 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders

IQVIA Holdings Inc., a corporation organized and existing under the laws of the State of Delaware, as amended (the “Corporation”), does hereby certify as follows:

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support